Form 4 for GPCR Structure Therapeutics Inc.

Accepted 2023-02-09 00:00:00 ET · period of report 2023-02-07 · accession 0001209191-23-008168 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2023-02-09	2023-02-07	GPCR	WELCH DANIEL G	Dir	C - Cnv Deriv	—	+123.5K	123.5K	New	—
DI	2023-02-09	2023-02-07	GPCR	WELCH DANIEL G	Dir	C - Cnv Deriv	—	-123.5K	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2023-02-07	C	A	123,508	—	123,508	I By spouse	—	—	(F1) All outstanding Preferred Shares automatically converted into Ordinary Shares immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date.
2	Derivative	Series B Preferred Shares	2023-02-07	C	D	123,508	—	0	I By spouse	— · — to —	123,508 Ordinary Shares	(F1) All outstanding Preferred Shares automatically converted into Ordinary Shares immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date.